In the cohort from the general neurochemistry laboratory, only about half of the patients with very high CSF-tau values (>1250 pg/mL) were diagnosed with prion diseases (25%), AD (23%), or other neurodegenerative diseases (mixed or single pathologies: 7%). Here, MAPT is linked to neurodegenerative disease.